The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.
© Clarivate Analytics, Journal Citation Reports 2025
Journal Information
Ahead of print
Ahead of print are accepted, peer reviewed articles that are not yet assigned to volumes/issues, but are citable using DOI. More info
Severe Cutaneous Signs of Hipersensitivity to Drugs in a Pediatric Hospital
H.M. Suárez-Bustamante, J.A. Alonso-Cadenas, L. Noguera Morel, C. Escudero Diez, R. Jiménez García, M. de la Torre Espí
10.1016/j.ad.2025.104586
Full text access
Uncorrected Proof. Available online 13 January 2026
Accessibility as a Key Factor in the Clinical Evolution and Therapeutic Management of Patients With Hidradenitis Suppurativa
F.J. León Pérez, C. García Moronta, S.M. Haselgruber de Francisco, D. Muñoz Barba, C. Cuenca Barrales, S. Arias Santiago, A. Molina Leyva
10.1016/j.ad.2025.104589
Full text access
Uncorrected Proof. Available online 12 January 2026
Role of Oral Tetracyclines in Preventing Acneiform Rash in Patients With Non-small Cell Lung Cancer Treated With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Systematic Review
R. Sousa, B. Vieira Granja, S. Magina
10.1016/j.ad.2025.104583
Full text access
Uncorrected Proof. Available online 12 January 2026
Translation, Cross-cultural Adaptation, Correlation With Other PROMs and Validation of the MF/SS-CTCL-QoL Questionnaire on Quality of Life in Mycosis Fungoides (MF) and Sézary Syndrome (SS)
M.M. Onteniente-Gomis, S.I. Palencia Perez, F.J. Ortiz de Frutos, C.M. García Álvarez, C. Martin Arriscado Arroba, C. Varela Rodriguez, P.L. Ortiz-Romero
10.1016/j.ad.2025.104584
Full text access
Uncorrected Proof. Available online 5 January 2026
Evaluation of the Efficacy of Photoprotective Formulations Applied in Conjunction With Topical Active Ingredients in Patients With Photodermatoses
R. Castillo-Muñoz, J. Aguilera, E. Navarrete-De Gálvez, E. Herrera-Acosta, J.A. Suárez-Pérez, C. Sánchez-Roldán, L. Martínez-Pilar, D.J. Godoy-Díaz, ... M.V. De Gálvez
10.1016/j.ad.2025.104581
Full text access
Uncorrected Proof. Available online 2 January 2026
Cost-consequence Analysis of Secukinumab vs Adalimumab in Moderate-to-severe Hidradenitis Suppurativa
A. Martorell Calatayud, A. Molina-Leyva, A. Jiménez Morales, C. Blanch
10.1016/j.ad.2025.104582
Full text access
Uncorrected Proof. Available online 1 January 2026
A Decade of Biologic Therapy for Hidradenitis Suppurativa: What Have We Achieved?
J. Romaní
10.1016/j.ad.2025.104574
Full text access
Uncorrected Proof. Available online 31 December 2025
Adnexal Tumours: The Unconditional Help of Dermoscopy
L.M. Nieto-Benito, M. Garrido-Ruiz, M. Huerta-Brogeras, A. Tomás-Velázquez, P. Redondo-Ballón
10.1016/j.ad.2025.104576
Full text access
Uncorrected Proof. Available online 31 December 2025
Bilateral Hand Swelling as a Sign of Systemic Amyloidosis
M.A. Sirvent-Sáez, A.I. Sánchez-Del-Campo, D. Moreno-Ramírez
10.1016/j.ad.2025.104577
Full text access
Uncorrected Proof. Available online 31 December 2025
Linezolid, an Alternative to Ertapenem in Recalcitrant Hidradenitis Suppurativa: A Series of 6 Cases
T.L. Vega López, L. Aguilar González, R.P. Román Cheuque, D. Jiménez Gallo
10.1016/j.ad.2025.104575
Full text access
Uncorrected Proof. Available online 31 December 2025

